Epilepsy Market SWOT and PEST Analysis 2020-2030
The epilepsy market size is projected to grow from US$ 7.7 billion in 2022 to US$ 10.7 billion by 2030; it is estimated to record a CAGR of 4.1% during 2022–2030. Key factors driving the market growth are rising prevalence of epilepsy and increasing investments in development of epilepsy therapies. However, recall of products may hinder the market growth to a certain extent.
Epilepsy Market Analysis
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages. According to the Centers for Disease Control and Prevention, it is estimated that 1.2% of people in the United States have active epilepsy.
Epilepsy Market Overview
Epilepsy may occur due to some genetic disorder or may be due to some acquired brain injury, such as a trauma or stroke. According to recent report published by the World Health Organization (WHO) in February 2023, epilepsy accounts for a significant share of the worldwide disease burden, affecting nearly fifty million people across the world. Moreover, 4–10 persons per 1,000 individuals are estimated to have active epilepsy (i.e., with the need for treatment or continuing seizures). Nearly 5 million people are diagnosed with epilepsy every year. High-income countries are estimated to report high epilepsy at a rate of 49 per 100,000 people annually. This number can reach 139 per 100,000 individuals in low- and middle-income countries. An upsurge in epilepsy incidence can be attributed to the higher count of road traffic injuries and birth-related injuries, and the elevated risk of endemic conditions such as neurocysticercosis or malaria. The WHO also states that approximately 70% of individuals with epilepsy can become seizure-free with the use of medications.
Treatments to control epilepsy include anti-epileptic medications, special diets (in addition to anti-seizure medications), and surgery; however, anti-epileptic drug therapy is the primary treatment prescribed for most patients. Thus, the rising prevalence of epilepsy worldwide drives market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Epilepsy Market: Strategic Insights
Market Size Value in US$ 7.7 billion in 2022 Market Size Value by US$ 10.7 billion by 2030 Growth rate CAGR of 4.1% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Epilepsy Market: Strategic Insights
| Market Size Value in | US$ 7.7 billion in 2022 |
| Market Size Value by | US$ 10.7 billion by 2030 |
| Growth rate | CAGR of 4.1% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Epilepsy Market Drivers and Opportunities
Increasing Investments in the Development of Epilepsy Therapies Favors Market
The healthcare sector is transforming with rapid technological developments and innovation, enhancing healthcare services and quality of care. The epilepsy market is characterized by several small and large companies and organizations implementing various growth strategies. The availability of funding enables companies and organizations to boost production levels, expand into new markets, invest in new/improved technologies, and allocate more resources to R&D. A few of the notable investments in the epilepsy market, contributing to the market progress, have been mentioned below
- In March 2023, the Swedish government decided to commission Vinnova, Sweden’s innovation agency, a total of US$ 7.7 million (80 million SEK) to establish a national innovation cluster for commercialization, skills development, and production capacity build-up for cell therapies and other advanced treatments such as gene therapy.
- In November 2022, Scientists at Aston University in the UK, working on a project to develop new drug treatments to prevent the beginning of childhood epilepsy, were awarded US$ 2.4 million (£2 million) to discover the disease mechanism in the brain and the ways of epilepsy prevention. This 3-year project funded by the Medical Research Council is a collaboration led by researchers in the College of Health and Life Sciences at Aston University, combined with Bristol University and Jazz Pharmaceutical.
Awareness Programs Conducted by Organizations – An Opportunity in Epilepsy Market
Growing awareness about epilepsy, its symptoms, and the importance of early diagnosis has led to a surge in patients seeking medical attention. Organizations such as the Epilepsy Foundation, Epilepsy Society, the American Epilepsy Society, and the Epilepsy Association of Central Florida play a crucial role in educating people about this disease. The involvement of these organizations has resulted in increased rates of diagnosis and a broader patient population requiring epilepsy treatment.
Numerous awareness campaigns are conducted by organizations globally to spread awareness regarding the disease condition and available treatment. In the US, Epilepsy Awareness Day or Purple Day is observed on March 26 every year to raise public understanding of the brain disorder, along with eliminating its fear and stigma. Similarly, November is reserved as National Epilepsy Awareness Month (NEAM) in the US every year to educate people about the condition and symptoms of epilepsy and raise funds for research related to managing this disease. The Epilepsy Foundation selects a theme that encourages people to collaborate and act to promote awareness and funds for epilepsy. In November 2021, the foundation launched the #RemoveTheFilter social media campaign to reduce fear associated with epilepsy and bring hope to those suffering from the condition.
Moreover, in partnership with SK Life Science Inc., the Epilepsy Foundation introduced a 30-minute on-demand course for people to learn the essentials of seizure first aid. The UK Sudden Unexpected Death in Epilepsy (SUDEP) Awareness Day is celebrated on October 23. The SUDEP action leads the international epilepsy community to recognize and raise awareness about sudden and unexpected death due to epilepsy. Thus, such initiatives and awareness campaigns increase epilepsy diagnoses and treatments, offering lucrative growth opportunities to the market.
Epilepsy Market Report Segmentation Analysis
Key segments that contributed to the derivation of the epilepsy market analysis are type, route of administration, treatment type, age group, and distribution channel.
- Based on type, the epilepsy market is divided into progressive myoclonic epilepsy, reflex epilepsy, generalized epilepsy, and others. The generalized epilepsy segment held a higher market share in 2022.
- Based on route of administration, the market is segmented into oral, parenteral, other route of administration.
- In terms of treatment type, the market is segmented into first generation drugs, second generation drugs, and third generation drugs.
- In terms of age group, the market is segmented into adult and children.
- In terms of distribution channel, the market is segmented hospital pharmacies, retail pharmacies, and other distribution channel
Epilepsy Market Share Analysis by Geography
The geographic scope of the epilepsy market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
In North America, the epilepsy market is currently experiencing exponential growth during the forecast years. The US market dominates the global epilepsy market in 2022. The burgeoning number of cases of neurological diseases such as Alzheimer's disease, increasing awareness about neurological disorders, favourable results obtained in research activities, and growing investments in developing epilepsy drugs are among the main factors driving the overall epilepsy market growth in the US. In March 2020, Neurelis, Inc. announced the commercial availability of VALTOCO (diazepam nasal spray) to treat stereotypic, intermittent episodes of frequent seizures (i.e., acute repetitive seizures and seizure clusters) that are different from a usual seizure pattern observed in pediatric and adult patients. Similarly, in March 2022, the FDA approved Ztalmy (ganaxolone) to treat seizures related to cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients aged 2 and older.
In August 2021, the CDC Epilepsy Program selected the Epilepsy Foundation as its funding recipient under a new cooperative agreement: Improving Systems of Care, Epilepsy Education, and Health Outcomes through National and Community Partnerships. The US$ 17.5 million in federal funds that would be allotted over the next 5 years would support the work of the Epilepsy Foundation and its partners in creating and maintaining a robust public health infrastructure, advancing health equity, improving quality of life, and achieving the best outcomes for all people living with the epilepsies. Therefore, the increasing prevalence of epilepsy, new drug launches, and research and funding initiatives bolster the epilepsy market size in the US.
Epilepsy Market Report Scope
Epilepsy Market News and Recent Developments
The epilepsy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:
- In May 2023, the biotechnology company Neuro3 Therapeutics (Neuro3), which focuses on finding and creating novel medications to treat illnesses of the central nervous system has signed an exclusive global license and option deal with Lundbeck. The agreement focuses on KCNQ2 ion channel activators, which have been clinically verified as targets for epilepsy treatment. According to clinical research, KCNQ2 channel activation may offer therapeutic alternatives for treating various neurological conditions, such as uncommon forms of epilepsy. (Source: Neuro3 Therapeutics company website)
Epilepsy Market Report Coverage and Deliverables
The “Epilepsy Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering the following areas:
- Epilepsy Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Epilepsy Market trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Epilepsy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Epilepsy Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Route of Administration, Treatment Type, Age Group, Distribution Channel, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 4.10% during 2023–2031.
Abbott Laboratories, Pfizer Inc., Eisai Co Ltd., UCB SA, CombiGene AB, LivaNova Plc, Novartis AG, Medtronic Plc, GSK Plc, and H. Lundbeck AS
The high-throughput genetic sequencing technique enables a faster and more comprehensive analysis of DNA, thereby aiding the identification of genetic causes of conditions such as epilepsy are likely to remain a key trend in the market.
The rising prevalence of epilepsy and increasing investments in development of epilepsy therapies are the major factors fuelling the market growth of epilepsy over the years.
North America dominated the epilepsy market in 2023
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Epilepsy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Epilepsy Market – Key Market Dynamics
5.1 Epilepsy Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Epilepsy
5.2.2 Increasing Investments in Development of Epilepsy Therapies
5.3 Market Restraints
5.3.1 Recall of Products
5.4 Market Opportunities
5.4.1 Surge in Awareness Programs Conducted by Organizations
5.5 Future Trends
5.5.1 Gene Therapy as Promising Treatment Approach
5.6 Impact of Drivers and Restraints:
6. Epilepsy Market – Global Market Analysis
6.1 Epilepsy Market Revenue (US$ Million), 2022–2030
7. Epilepsy Market Analysis – by Type
7.1 Overview
7.2 Progressive Myoclonic Epilepsy
7.2.1 Overview
7.2.2 Progressive Myoclonic Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Reflex Epilepsy
7.3.1 Overview
7.3.2 Reflex Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Generalized Epilepsy
7.4.1 Overview
7.4.2 Generalized Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Other
7.5.1 Overview
7.5.2 Other: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
8. Epilepsy Market Analysis – by Route of Administration
8.1 Overview
8.2 Oral
8.2.1 Overview
8.2.2 Oral: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Parenteral
8.3.1 Overview
8.3.2 Parenteral: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
9. Epilepsy Market Analysis – by Treatment Type
9.1 Overview
9.2 First Generation Drugs
9.2.1 Overview
9.2.2 First Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Second Generation Drugs
9.3.1 Overview
9.3.2 Second Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Third Generation Drugs
9.4.1 Overview
9.4.2 Third Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
10. Epilepsy Market Analysis – by Age Group
10.1 Overview
10.2 Adult
10.2.1 Overview
10.2.2 Adult: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Children
10.3.1 Overview
10.3.2 Children: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
11. Epilepsy Market Analysis – by Distribution Channel
11.1 Overview
11.2 Hospital Pharmacies
11.2.1 Overview
11.2.2 Hospital Pharmacies: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
11.3 Retail Pharmacies
11.3.1 Overview
11.3.2 Retail Pharmacies: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12. Epilepsy Market – Geographical Analysis
12.1 North America: Epilepsy Market
12.1.1 Overview
12.1.2 North America: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.2.1 North America: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.1.2.2 North America: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.1.2.3 North America: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.1.2.4 North America: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.1.2.5 North America: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.1.3 North America: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.1.3.1 United States: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.1.1 Overview
12.1.3.1.2 United States: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.1.3 United States: Epilepsy Market Breakdown, by Type
12.1.3.1.4 United States: Epilepsy Market Breakdown, by Route of Administration
12.1.3.1.5 United States: Epilepsy Market Breakdown, by Treatment Type
12.1.3.1.6 United States: Epilepsy Market Breakdown, by Age Group
12.1.3.1.7 United States: Epilepsy Market Breakdown, by Distribution Channel
12.1.3.2 Canada: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.2.1 Overview
12.1.3.3 Canada: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.3.1 Canada: Epilepsy Market Breakdown, by Type
12.1.3.3.2 Canada: Epilepsy Market Breakdown, by Route of Administration
12.1.3.3.3 Canada: Epilepsy Market Breakdown, by Treatment Type
12.1.3.3.4 Canada: Epilepsy Market Breakdown, by Age Group
12.1.3.3.5 Canada: Epilepsy Market Breakdown, by Distribution Channel
12.1.3.4 Mexico: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.4.1 Overview
12.1.3.5 Mexico: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.5.1 Mexico: Epilepsy Market Breakdown, by Type
12.1.3.5.2 Mexico: Epilepsy Market Breakdown, by Route of Administration
12.1.3.5.3 Mexico: Epilepsy Market Breakdown, by Treatment Type
12.1.3.5.4 Mexico: Epilepsy Market Breakdown, by Age Group
12.1.3.5.5 Mexico: Epilepsy Market Breakdown, by Distribution Channel
12.2 Europe: Epilepsy Market
12.2.1 Overview
12.2.2 Europe: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.2.1 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.2.2.2 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.2.2.3 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.2.2.4 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.2.2.5 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.2.3 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.2.3.1 United Kingdom: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.1.1 Overview
12.2.3.2 United Kingdom: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.2.1 United Kingdom: Epilepsy Market Breakdown, by Type
12.2.3.2.2 United Kingdom: Epilepsy Market Breakdown, by Route of Administration
12.2.3.2.3 United Kingdom: Epilepsy Market Breakdown, by Treatment Type
12.2.3.2.4 United Kingdom: Epilepsy Market Breakdown, by Age Group
12.2.3.2.5 United Kingdom: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.3 Germany: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.3.1 Overview
12.2.3.4 Germany: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.4.1 Germany: Epilepsy Market Breakdown, by Type
12.2.3.4.2 Germany: Epilepsy Market Breakdown, by Route of Administration
12.2.3.4.3 Germany: Epilepsy Market Breakdown, by Treatment Type
12.2.3.4.4 Germany: Epilepsy Market Breakdown, by Age Group
12.2.3.4.5 Germany: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.5 France: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.5.1 Overview
12.2.3.6 France: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.6.1 France: Epilepsy Market Breakdown, by Type
12.2.3.6.2 France: Epilepsy Market Breakdown, by Route of Administration
12.2.3.6.3 France: Epilepsy Market Breakdown, by Treatment Type
12.2.3.6.4 France: Epilepsy Market Breakdown, by Age Group
12.2.3.6.5 France: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.7 Spain: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.7.1 Overview
12.2.3.8 Spain: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.8.1 Spain: Epilepsy Market Breakdown, by Type
12.2.3.8.2 Spain: Epilepsy Market Breakdown, by Route of Administration
12.2.3.8.3 Spain: Epilepsy Market Breakdown, by Treatment Type
12.2.3.8.4 Spain: Epilepsy Market Breakdown, by Age Group
12.2.3.8.5 Spain: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.9 Italy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.9.1 Overview
12.2.3.10 Italy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.10.1 Italy: Epilepsy Market Breakdown, by Type
12.2.3.10.2 Italy: Epilepsy Market Breakdown, by Route of Administration
12.2.3.10.3 Italy: Epilepsy Market Breakdown, by Treatment Type
12.2.3.10.4 Italy: Epilepsy Market Breakdown, by Age Group
12.2.3.10.5 Italy: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.11 Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.11.1 Overview
12.2.3.12 Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.12.1 Rest of Europe: Epilepsy Market Breakdown, by Type
12.2.3.12.2 Rest of Europe: Epilepsy Market Breakdown, by Route of Administration
12.2.3.12.3 Rest of Europe: Epilepsy Market Breakdown, by Treatment Type
12.2.3.12.4 Rest of Europe: Epilepsy Market Breakdown, by Age Group
12.2.3.12.5 Rest of Europe: Epilepsy Market Breakdown, by Distribution Channel
12.3 Asia Pacific: Epilepsy Market
12.3.1 Overview
12.3.2 Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.2.1 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.3.2.2 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.3.2.3 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.3.2.4 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.3.2.5 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.3.3 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.3.3.1 China: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.1.1 Overview
12.3.3.2 China: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.2.1 China: Epilepsy Market Breakdown, by Type
12.3.3.2.2 China: Epilepsy Market Breakdown, by Route of Administration
12.3.3.2.3 China: Epilepsy Market Breakdown, by Treatment Type
12.3.3.2.4 China: Epilepsy Market Breakdown, by Age Group
12.3.3.2.5 China: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.3 Japan: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.3.1 Overview
12.3.3.4 Japan: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.4.1 Japan: Epilepsy Market Breakdown, by Type
12.3.3.4.2 Japan: Epilepsy Market Breakdown, by Route of Administration
12.3.3.4.3 Japan: Epilepsy Market Breakdown, by Treatment Type
12.3.3.4.4 Japan: Epilepsy Market Breakdown, by Age Group
12.3.3.4.5 Japan: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.5 India: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.5.1 Overview
12.3.3.6 India: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.6.1 India: Epilepsy Market Breakdown, by Type
12.3.3.6.2 India: Epilepsy Market Breakdown, by Route of Administration
12.3.3.6.3 India: Epilepsy Market Breakdown, by Treatment Type
12.3.3.6.4 India: Epilepsy Market Breakdown, by Age Group
12.3.3.6.5 India: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.7 Australia: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.7.1 Overview
12.3.3.8 Australia: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.8.1 Australia: Epilepsy Market Breakdown, by Type
12.3.3.8.2 Australia: Epilepsy Market Breakdown, by Route of Administration
12.3.3.8.3 Australia: Epilepsy Market Breakdown, by Treatment Type
12.3.3.8.4 Australia: Epilepsy Market Breakdown, by Age Group
12.3.3.8.5 Australia: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.9 South Korea: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.9.1 Overview
12.3.3.10 South Korea: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.10.1 South Korea: Epilepsy Market Breakdown, by Type
12.3.3.10.2 South Korea: Epilepsy Market Breakdown, by Route of Administration
12.3.3.10.3 South Korea: Epilepsy Market Breakdown, by Treatment Type
12.3.3.10.4 South Korea: Epilepsy Market Breakdown, by Age Group
12.3.3.10.5 South Korea: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.11 Rest of Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.11.1 Overview
12.3.3.12 Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.12.1 Rest of APAC: Epilepsy Market Breakdown, by Type
12.3.3.12.2 Rest of APAC: Epilepsy Market Breakdown, by Route of Administration
12.3.3.12.3 Rest of APAC: Epilepsy Market Breakdown, by Treatment Type
12.3.3.12.4 Rest of APAC: Epilepsy Market Breakdown, by Age Group
12.3.3.12.5 Rest of APAC: Epilepsy Market Breakdown, by Distribution Channel
12.4 Middle East & Africa Epilepsy Market
12.4.1 Overview
12.4.2 Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.2.1 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.4.2.2 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.4.2.3 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.4.2.4 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.4.2.5 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.4.3 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.4.3.1 Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.1.1 Overview
12.4.3.2 Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.2.1 Saudi Arabia: Epilepsy Market Breakdown, by Type
12.4.3.2.2 Saudi Arabia: Epilepsy Market Breakdown, by Route of Administration
12.4.3.2.3 Saudi Arabia: Epilepsy Market Breakdown, by Treatment Type
12.4.3.2.4 Saudi Arabia: Epilepsy Market Breakdown, by Age Group
12.4.3.2.5 Saudi Arabia: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.3 South Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.3.1 Overview
12.4.3.4 South Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.4.1 South Africa: Epilepsy Market Breakdown, by Type
12.4.3.4.2 South Africa: Epilepsy Market Breakdown, by Route of Administration
12.4.3.4.3 South Africa: Epilepsy Market Breakdown, by Treatment Type
12.4.3.4.4 South Africa: Epilepsy Market Breakdown, by Age Group
12.4.3.4.5 South Africa: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.5 United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.5.1 Overview
12.4.3.6 United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.6.1 United Arab Emirates: Epilepsy Market Breakdown, by Type
12.4.3.6.2 United Arab Emirates: Epilepsy Market Breakdown, by Route of Administration
12.4.3.6.3 United Arab Emirates: Epilepsy Market Breakdown, by Treatment Type
12.4.3.6.4 United Arab Emirates: Epilepsy Market Breakdown, by Age Group
12.4.3.6.5 United Arab Emirates: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.7 Rest of Middle East & Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.7.1 Overview
12.4.3.8 Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.8.1 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Type
12.4.3.8.2 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Route of Administration
12.4.3.8.3 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Treatment Type
12.4.3.8.4 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Age Group
12.4.3.8.5 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Distribution Channel
12.5 South & Central America: Epilepsy Market
12.5.1 Overview
12.5.2 South and Central America: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.2.1 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.5.2.2 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.5.2.3 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.5.2.4 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.5.2.5 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.5.3 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.5.3.1 Brazil: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.1.1 Overview
12.5.3.2 Brazil: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.2.1 Brazil: Epilepsy Market Breakdown, by Type
12.5.3.2.2 Brazil: Epilepsy Market Breakdown, by Route of Administration
12.5.3.2.3 Brazil: Epilepsy Market Breakdown, by Treatment Type
12.5.3.2.4 Brazil: Epilepsy Market Breakdown, by Age Group
12.5.3.2.5 Brazil: Epilepsy Market Breakdown, by Distribution Channel
12.5.3.3 Argentina: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.3.1 Overview
12.5.3.4 Argentina: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.4.1 Argentina: Epilepsy Market Breakdown, by Type
12.5.3.4.2 Argentina: Epilepsy Market Breakdown, by Route of Administration
12.5.3.4.3 Argentina: Epilepsy Market Breakdown, by Treatment Type
12.5.3.4.4 Argentina: Epilepsy Market Breakdown, by Age Group
12.5.3.4.5 Argentina: Epilepsy Market Breakdown, by Distribution Channel
12.5.3.5 Rest of South & Central America: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.5.1 Overview
12.5.3.6 Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.6.1 Rest of South and Central America: Epilepsy Market Breakdown, by Type
12.5.3.6.2 Rest of South and Central America: Epilepsy Market Breakdown, by Route of Administration
12.5.3.6.3 Rest of South and Central America: Epilepsy Market Breakdown, by Treatment Type
12.5.3.6.4 Rest of South and Central America: Epilepsy Market Breakdown, by Age Group
12.5.3.6.5 Rest of South and Central America: Epilepsy Market Breakdown, by Distribution Channel
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Epilepsy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Pfizer Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Eisai Co Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 UCB SA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 CombiGene AB
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 LivaNova Plc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Medtronic Plc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 GSK Plc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 H. Lundbeck AS
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
List of Tables
Table 1. Epilepsy Market Segmentation
Table 2. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 3. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 4. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 5. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 6. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 7. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 8. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 9. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 10. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 11. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 12. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 13. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 14. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 15. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 16. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 17. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 18. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 19. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 20. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 21. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 22. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 23. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 24. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 25. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 26. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 27. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 28. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 29. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 30. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 31. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 32. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 33. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 34. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 35. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 36. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 37. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 38. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 39. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 40. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 41. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 42. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 43. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 44. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 45. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 46. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 47. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 48. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 49. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 50. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 51. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 52. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 53. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 54. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 55. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 56. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 57. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 58. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 59. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 60. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 61. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 62. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 63. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 64. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 65. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 66. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 67. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 68. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 69. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 70. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 71. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 72. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 73. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 74. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 75. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 76. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 77. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 78. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 79. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 80. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 81. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 82. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 83. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 84. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 85. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 86. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 87. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 88. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 89. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 90. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 91. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 92. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 93. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 94. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 95. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 96. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 97. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 98. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 99. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 100. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 101. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 102. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 103. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 104. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 105. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 106. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 107. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 108. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 109. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 110. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 111. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 112. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 113. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 114. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 115. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 116. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 117. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 118. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 119. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 120. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 121. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 122. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 123. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 124. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 125. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 126. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 127. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 128. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 129. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 130. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 131. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 132. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 133. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 134. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 135. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 136. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 137. Recent Organic Growth Strategies in Epilepsy Market
Table 138. Recent Inorganic Growth Strategies in the Epilepsy Market
List of Figures
Figure 1. Epilepsy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Epilepsy Market Revenue (US$ Million), 2022–2030
Figure 5. Epilepsy Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 6. Epilepsy Market Share (%) – by Type (2022 and 2030)
Figure 7. Progressive Myoclonic Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Reflex Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Generalized Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Other: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Epilepsy Market Share (%) – by Route of Administration (2022 and 2030)
Figure 12. Oral: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Parenteral: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy Market Share (%) – by Treatment Type (2022 and 2030)
Figure 16. First Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Second Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Third Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Epilepsy Market Share (%) – by Age Group (2022 and 2030)
Figure 20. Adult: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Children: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Epilepsy Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 23. Hospital Pharmacies: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Retail Pharmacies: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. North America: Epilepsy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 27. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. North America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 29. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 31. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 32. Europe: Epilepsy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 33. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 34. Europe: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 35. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 36. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 38. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 39. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 40. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 41. Asia Pacific: Epilepsy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 42. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Asia Pacific: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 44. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 45. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 46. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 47. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 48. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 49. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 50. Middle East & Africa: Epilepsy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 51. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 52. Middle East and Africa: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 54. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 55. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 56. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 57. South & Central America: Epilepsy Market, By Key Country – Revenue (2022) (US$ Million)
Figure 58. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 59. South and Central America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 60. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 61. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 62. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 63. Growth Strategies in Epilepsy Market
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For